Treating ETTCL: A matter of early diagnosis and chemotherapy strategies

Digestive and Liver Disease

Volumn 39, Issue 7, 2007, Pages 642-645

  Ciccocioppo, R ^a   Perfetti, V ^a   Corazza, G R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CARMUSTINE; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; HISTONE DEACETYLASE INHIBITOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; NELARABINE; NUCLEOSIDE ANALOG; OBLIMERSEN; PREDNISONE; TEMSIROLIMUS; VINCRISTINE; VORINOSTAT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; EARLY DIAGNOSIS; ENTEROPATHY; FOLLOW UP; HUMAN; LYMPHOCYTOPENIA; MALIGNANT TRANSFORMATION; MORBIDITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; T CELL LYMPHOMA;

EID: 34250028616     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.04.009     Document Type: Note

References (34)

1. Brenner M.K. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential. Best Pract Res Clin Haematol 17 (2004) 359-374
2. Oyama Y., Craig R.M., Traynor A.E., Quigley K., Statkute L., Halverson A., et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128 (2005) 552-563
3. Al-toma A., Visser O.J., van Roessel H.M., von Blomberg M.E., Verbeek W.H.M., Scholten P.E.T., et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells. Blood 109 (2007) 2243-2249
4. Al-toma A., Verbeek W.H.M., Visser O.J., Kuijpers K.C., Oudejans J.J., Kluin-Nelemans H.C., et al. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis 39 (2007) 634-641
5. Corrao G., Corazza G.R., Bagnardi V., Brusco G., Ciacci C., Cottone M., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358 (2001) 356-361
6. Bagdi E., Diss T.C., Munson P., and Isaacson P.G. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1 (1999) 260-264
7. Meresse B., Curran S.A., Ciszewski C., Orbelyan G., Setty M., Bhagat G., et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 203 (2006) 1343-1355
8. Cellier C., Patey N., Mauvieux L., Jabry B., Delabesse E., Cervoni J.-P., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114 (1998) 471-481
9. Di Sabatino A., Ciccocioppo R., Cupelli F., Cinque B., Millimaggi D., Clarkson M.M., et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55 (2006) 469-477
10. Di Sabatino A., Ciccocioppo R., D'Alò S., Parroni R., Millimaggi D., Cifone M.G., et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis, whereas both populations are active in Fas-based cytotoxicity in coeliac disease. Gut 49 (2001) 380-386
11. Mention J.J., Ben Ahmed M., Bègue B., Barbe U., Verkarre V., Asnafi V., et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125 (2003) 730-745
12. Daum S., Cellier C., and Mulder C.J.J. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 19 (2005) 413-424
13. Daum S., Weiss D., Hummel M., Ullrich R., Heise W., Stein H., et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T-cell lymphoma, celiac disease and refractory sprue. Gut 49 (2001) 804-812
14. Wright D.H., Jones D.B., Clark H., Mead G.M., Hodges E., and Howell W.M. Is adult-onset coeliac disease due to a low-grade lymphoma of intraepithelial T lymphocytes?. Lancet 337 (1991) 1373-1374
15. Verkarre V., Romana S.P., Cellier C., Asnafi V., Mention J.J., Barbe U., et al. Recurrent partial trisomy 1q22-q44 in clonal intraeithelial lymphocytes in refractory celiac sprue. Gastroenterology 125 (2003) 40-46
16. Obermann E.C., Diss T.C., Hamoudi R.A., Munson P., Wilkins B.S., Camozzi M.L., et al. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma. J Pathol 202 (2004) 252-262
17. Al-toma A., Goerres M.S., Meijer J.W.R., Peña A.S., Crusius J.B.A., and Mulder C.J.J. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 4 (2006) 315-319
18. Gale J., Simmonds P., Mead G., Sweetenham J.W., and Wright D.H. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 18 (2000) 795-803
19. Joyce A.M., Burns D.L., Marcello P.W., Tronic B., and Scholz F.J. Capsule endoscopy findings in celiac disease associated enteropathy-type intestinal T-cell lymphoma. Endoscopy 37 (2005) 594-596
20. Heine G.D., Al-toma A., Mulder C.J., and Jacobs M.A. Milestone in gastrointestinal endoscopy: double-balloon enteroscopy of the small bowel. Scand J Gastroenterol 41 (2006) 32-38
21. Hoffmann M., Vogelsang H., Kletter K., Zettinig G., Chott A., and Raderer M. 18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 52 (2003) 347-351
22. 18F-FDG-PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 47 (2006) 1622-1627
23. Al-toma A., Goerres M.S., Meijer J.W.R., von Blomberg M.E., Wahab P.J., Kerckhaert J.A.M., et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 4 (2006) 1322-1327
24. Vivas S., Ruiz de Morales J.M., Ramos F., and Suàrez-Vilela D. Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. N Engl J Med 354 (2006) 2514-2515
25. Verbeek W.H.M., Mulder C.J., and Zweegman S. Alemtuzumab for refractory celiac disease. N Engl J Med 355 (2006) 1396-1397
26. Lundin K.E., Farstad I.N., Raki M., Benestad Y., Hoie O., and Tjonnfjord G. Alemtuzumab treatment of refractory celiac disease type II. Gastroenterology 130 (2006) A666
27. van Heel D.A. Interleukin 15: its role in intestinal inflammation. Gut 55 (2006) 444-445
28. Howdle P.D., Jalal P.K., Holmes G.K.T., and Houlston R.S. Primary small-bowel malignancy in the UK and its association with coeliac disease. Q J Med 96 (2003) 345-353
29. Cheson B.D. New drugs for peripheral T-cell lymphomas. Haematologica Rep 2 (2006) 42-45
30. Okuda M., Nomura J., Tateno H., Kameoka J., and Sasaki T. CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation. Int Med 41 (2002) 734-737
31. Rongey C., Micallef I., Smyrk T., and Murray J. Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant. Dig Dis Sci 51 (2006) 1082-1086
32. Bishton M.J., and Haynes A.P. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma. Br J Haematol 136 (2007) 111-113
33. Jantunen E., Juvonen E., Wiklund T., Putkonen M., and Nousiainen T. High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. Leuk Lymphoma 44 (2003) 2163-2164
34. Lennard A. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma. Br J Haematol 137 (2007) 170